Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
Canada
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Chocola A
2. Retinol Palmitate
3. Retinyl Palmitate
1. Retinyl Palmitate
2. 79-81-2
3. Retinol Palmitate
4. Retinol, Hexadecanoate
5. All-trans-retinyl Palmitate
6. Arovit
7. Optovit-a
8. Retinyl Hexadecanoate
9. Aquapalm
10. Dispatabs Tabs
11. Vitazyme A
12. Optovit A
13. Axerophthol Palmitate
14. Trans-retinol Palmitate
15. Trans-retinyl Palmitate
16. [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] Hexadecanoate
17. Lutavit A 500 Plus
18. All-trans-retinol Palmitate
19. Arovit (roche)
20. All-trans-vitamin A Palmitate
21. Aquasol A (tn)
22. Retinyl (vitamin A) Palmitate
23. Retinol Palmitate [jan]
24. O~15~-hexadecanoylretinol
25. Nsc-758478
26. 1d1k0n0vvc
27. Retinol, Palmitate, All-trans
28. Ester Found In Fish Liver Oils
29. Retinol Palmitate (6ci,7ci)
30. Chebi:17616
31. Palmitic Acid, Ester With Retinol
32. Retinol, Palmitate, All-trans- (8ci)
33. Ncgc00095056-03
34. Dsstox_cid_1241
35. Dsstox_rid_76033
36. Dsstox_gsid_21241
37. (2e,4e,6e,8e)-hexadecanoic Acid 3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2, 4,6,8,tetraenyl Ester
38. Vitamin A Solubilized
39. Cas-79-81-2
40. (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl Hexadecanoate
41. Smr000112463
42. Ccris 3280
43. Retinol, Palmitate, All-trans-
44. Einecs 201-228-5
45. Unii-1d1k0n0vvc
46. Brn 1917366
47. Retinylpalmitate
48. Retinol-palmitate
49. Retinyl-palmitate
50. Retinol, All-trans-, Palmitate
51. Palmitic Acid Retinol
52. Retinyl Palmitic Acid
53. Vitamin- A Palmitate
54. Retinyl Hexadecanoic Acid
55. Spectrum5_001201
56. All-(e)-retinol Palmitate
57. Bmse000501
58. Ec 201-228-5
59. Retinol Palmitate (jp17)
60. Chembl1675
61. Schembl41649
62. Mls001332437
63. Mls001332438
64. Spectrum1503604
65. All-trans-retinyl Hexadecanoate
66. Dtxsid1021241
67. Retinyl Palmitate [inci]
68. Hms500m11
69. Retinyl Palmitate [vandf]
70. Vitamin A Palmitate [mi]
71. Hms1922e10
72. Hms2093g13
73. Hms2268c06
74. Pharmakon1600-01503604
75. Retinol Palmitate [who-dd]
76. Retinyl Palmitate [usp-rs]
77. (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraen-1-yl Palmitate
78. Amy13840
79. Hy-b1384
80. Vae 16:0
81. Vitamin A Palmitate [vandf]
82. Zinc8214494
83. Tox21_113452
84. Tox21_303008
85. Ccg-39342
86. Lmpr01090013
87. Mfcd00019414
88. Nsc758478
89. S4126
90. Retinol, O~15~-(1-oxohexadecyl)-
91. Akos015918435
92. Nsc 758478
93. Vitamin A Palmitate, 1.7 M.i.u./g
94. Idi1_000249
95. Ncgc00095056-01
96. Ncgc00095056-02
97. Ncgc00256427-01
98. Ac-20001
99. Vitamin A Palmitate [orange Book]
100. Sbi-0051830.p002
101. All-(e)-retinol Palmitate [who-ip]
102. Cs-0013116
103. C02588
104. C76552
105. D00164
106. Ab00052360_04
107. A839762
108. Sr-05000001910
109. Vitamin A Palmitate (solubilized) [vandf]
110. Q7316807
111. Sr-05000001910-1
112. Retinyl Palmitate (vitamin A Palmitate; Retinol Palmitate)
113. Retinyl Palmitate, Potency: >=1,700,000 Usp Units Per G
114. Vitamin A (as Palmitate & Beta Carotene) [vandf]
115. Retinyl Palmitate, Type Iv, ~1,800,000 Usp Units/g, Oil
116. Retinyl Palmitate, United States Pharmacopeia (usp) Reference Standard
117. [3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] Hexadecanoate
118. 3,7-dimethyl-9-(2,6,6,-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraen-1-ol Palmitate
119. (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethyl-cyclohex-en-1-yl)-2,4,6,8-nonateetraen-1-yl-palmitate
120. (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenyl Palmitate
121. 110067-62-4
122. Hexadecanoic Acid [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenyl] Ester
123. Retinyl Palmitate (vitamin A Palmitate), Pharmaceutical Secondary Standard; Certified Reference Material
124. Retinyl Palmitate Solution, 100 Mug/ml (ethanol With 0.1% (w/v) Bht), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 524.9 g/mol |
---|---|
Molecular Formula | C36H60O2 |
XLogP3 | 13.6 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 21 |
Exact Mass | 524.45933115 g/mol |
Monoisotopic Mass | 524.45933115 g/mol |
Topological Polar Surface Area | 26.3 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 803 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 4 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anticarcinogenic Agents
Agents that reduce the frequency or rate of spontaneous or induced tumors independently of the mechanism involved. (See all compounds classified as Anticarcinogenic Agents.)
Antioxidants
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17708
Submission : 2004-09-14
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-07-14
Pay. Date : 2017-01-10
DMF Number : 31038
Submission : 2016-10-28
Status : Active
Type : II
Registration Number : 219MF10114
Registrant's Address : Wurmisweg 576, CH-4303, Kaiseraugst, Switzerland
Initial Date of Registration : 2007-03-23
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6581
Submission : 1986-08-28
Status : Inactive
Type : II
Registration Number : 222MF10268
Registrant's Address : 2-9-18 Misakicho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2010-12-10
Latest Date of Registration : --
Registration Number : 229MF10223
Registrant's Address : 2-9-18 Misakicho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2017-12-25
Latest Date of Registration : --
Registration Number : 217MF10450
Registrant's Address : 2-9-18 Misakicho, Chiyoda-ku, Tokyo
Initial Date of Registration : 2005-08-24
Latest Date of Registration : --
Registration Number : 218MF10103
Registrant's Address : Wurmisweg 576, CH-4303, Kaiseraugst, Switzerland
Initial Date of Registration : 2006-01-30
Latest Date of Registration : --
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6581
Submission : 1986-08-28
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-07-14
Pay. Date : 2017-01-10
DMF Number : 31038
Submission : 2016-10-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17708
Submission : 2004-09-14
Status : Active
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
The grant will allow the Company to position its novel aerosolized retinol palmitate (vitamin A) formulation for commercialization in 2025 to prevent Bronchopulmonary Dysplasia (BPD).
Lead Product(s): Vitamin A Palmitate
Therapeutic Area: Pulmonary/Respiratory Diseases Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Small molecule
Sponsor: National Institutes of Health
Deal Size: $3.0 million Upfront Cash: Undisclosed
Deal Type: Funding July 18, 2023
Lead Product(s) : Vitamin A Palmitate
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : National Institutes of Health
Deal Size : $3.0 million
Deal Type : Funding
Advent Therapeutics Awarded $3 Million NIH Grant for Novel Neonatal Lung Therapy
Details : The grant will allow the Company to position its novel aerosolized retinol palmitate (vitamin A) formulation for commercialization in 2025 to prevent Bronchopulmonary Dysplasia (BPD).
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Undisclosed
July 18, 2023
RLD : No
TE Code :
Brand Name : ALPHALIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50,000 UNITS BASE
Approval Date : 1982-01-01
Application Number : 80883
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : VITAMIN A
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50,000 UNITS BASE
Approval Date : 1982-01-01
Application Number : 80943
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : VITAMIN A
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50,000 UNITS BASE
Approval Date : 1982-01-01
Application Number : 83114
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : VITAMIN A
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50,000 UNITS BASE
Approval Date : 1982-01-01
Application Number : 83190
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : Yes
TE Code :
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
Brand Name : INFUVITE ADULT
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
Approval Date : 2000-05-18
Application Number : 21163
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : Yes
TE Code :
ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K
Brand Name : INFUVITE ADULT
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
Approval Date : 2003-06-16
Application Number : 21163
RX/OTC/DISCN : RX
RLD : Yes
TE Code :
RLD : No
TE Code :
Brand Name : AFAXIN
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50,000 UNITS BASE
Approval Date : 1982-01-01
Application Number : 83187
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code :
Brand Name : VITAMIN A SOLUBILIZED
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50,000 UNITS BASE
Approval Date : 1982-01-01
Application Number : 80921
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Brand Name : VITAMIN A
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 50,000 UNITS BASE
Approval Date : 1982-01-01
Application Number : 83457
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Brand Name : VITAMIN A
Dosage Form : CAPSULE;ORAL
Dosage Strength : EQ 25,000 UNITS BASE
Approval Date : 1982-01-01
Application Number : 83457
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Switzerland
Brand Name : Vitamin A Blache
Dosage Form : Eye Gel
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Regulatory Info :
Registration Country : Italy
Brand Name : Vitalipid
Dosage Form : Retinol Palmitate+Ergocalciferolo+Alpha Tocopherol+Phytomenadione 69+1+0,64+20Mcg 10 Units Parenteral Use
Dosage Strength : BB 10 VIALS EV 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Vitalipid
Dosage Form : Retinol Palmitate+Ergocalciferolo+Alpha Tocopherol+Phytomenadione 99+0,5+0,91+15Mcg 10 Units Parenteral Use
Dosage Strength : AD 10 VIALS EV 10 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?